|
1
|
World Cancer Report: International Agency
for Research on Cancer. 2008, Retrieved 2011-02-26. (cancer
statistics often exclude non-melanoma skin cancers such as basal
cell carcinoma which though very common are rarely fatal).
|
|
2
|
Ramachandran C and Melnick SJ: Multidrug
resistance in human tumors - molecular diagnosis and clinical
significance. Mol Diagn. 4:81–94. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gil J, Stembalska A, Pesz KA and Sasiadek
MM: Cancer stem cells: the theory and perspectives in cancer
therapy. J Appl Genet. 49:193–199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Robey RW, Shukla S, Finley EM, et al:
Inhibition of P-glycoprotein (ABCB1)- and multidrug
resistance-associated protein 1 (ABCC1)-mediated transport by the
orally administered inhibitor, CBT-1((R)). Biochem Pharmacol.
75:1302–1312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yanamoto S, Kawasaki G, Yoshitomi I,
Iwamoto T, Hirata K and Mizuno A: Clinicopathologic significance of
EpCAM expression in squamous cell carcinoma of the tongue and its
possibility as a potential target for tongue cancer gene therapy.
Oral Oncol. 43:869–877. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Britton KM, Eyre R, Harvey IJ, et al:
Breast cancer, side population cells and ABCG2 expression. Cancer
Lett. 323:97–105. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirschmann-Jax C, Foster AE, Wulf GG, et
al: A distinct ‘side population’ of cells with high drug efflux
capacity in human tumor cells. Proc Natl Acad USA. 101:14228–14233.
2004. View Article : Google Scholar
|
|
8
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side
population is enriched in tumorigenic, stem-like cancer cells,
whereas ABCG2+ and ABCG2− cancer cells are
similarly tumorigenic. Cancer Res. 65:6207–6219. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Welm BE, Tepera SB, Venezia T, et al:
Sca-1(pos) cells in the mouse mammary gland represent an enriched
progenitor cell population. Dev Biol. 245:42–56. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Clarke R, Spence K, Anderson E, Howell A,
Okano H and Potten C: A putative human breast stem cell population
is enriched for steroid receptor-positive cells. Dev Biol.
277:443–456. 2005. View Article : Google Scholar
|
|
12
|
Jonker JW, Freeman J, Bolscher E, et al:
Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side
population phenotype in mammary gland and bone marrow of mice. Stem
Cells. 23:1059–1065. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yanamoto S1, Kawasaki G, Yamada S,
Yoshitomi I, et al: Isolation and characterization of cancer
stem-like side population cells in human oral cancer cells. Oral
Oncol. 47:855–860. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Britton KM1, Eyre R, Harvey IJ,
Stemke-Hale K, et al: Breast cancer, side population cells and
ABCG2 expression. Cancer Lett. 323:97–105. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Faneyte IF, Kristel PM, Maliepaard M,
Scheffer GL, Scheper RJ, Schellens JH and van de Vijver MJ:
Expression of the breast cancer resistance protein n breast cancer.
Clin Cancer Res. 8:1068–1074. 2002.PubMed/NCBI
|
|
16
|
Nakanishi T, Chumsri S, Khakpour N, et al:
Side-population cells in luminal-type breast cancer have
tumour-initiating cell properties, and are regulated by HER2
expression and signaling. Br J Cancer. 102:815–826. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Engelmann K, Shen K and Finn OJ: MCF7 side
population cells with characteristics of cancer stem/progenitor
cells express the tumor antigen MUC1. Cancer Res. 68:2419–2426.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Campbell PA, Perez-Iratxeta C,
Andrade-Navarro MA and Rudnicki MA: Oct4 targets regulatory nodes
to modulate stem cell function. PLoS One. 2:e5532007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu T, Liu S, Breiter DR, Wang F, Tang Y
and Sun S: Octamer 4 small interfering RNA results in cancer stem
cell-like cell apoptosis. Cancer Res. 68:6533–6540. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Steiniger SC1, Coppinger JA, Krüger JA,
Yates J III and Janda KD: Quantitative mass spectrometry identifies
drug targets in cancer stem cell-containing side population. Stem
Cells. 26:3037–3046. 2008. View Article : Google Scholar : PubMed/NCBI
|
